LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 35

Search options

  1. Article: Improving Preservice Primary Teachers' Understanding of the Nature of Methods of Science Through Reflective Reading of News Articles.

    García-Carmona, Antonio

    Science & education

    2022  , Page(s) 1–21

    Abstract: A study is presented that analyzed the pedagogical efficacy of reading opinion articles about methods of science, published in the media, in order to improve the meta-scientific understanding of 52 preservice primary teachers (PPTs) with regard to the ... ...

    Abstract A study is presented that analyzed the pedagogical efficacy of reading opinion articles about methods of science, published in the media, in order to improve the meta-scientific understanding of 52 preservice primary teachers (PPTs) with regard to the topic. To this end, an activity was designed taking an explicit and reflective approach. The design of the activity required a short teaching intervention when being implemented in class in order to facilitate its integration into the program of the subject of science teaching. Before doing the activity, the PPTs' prior conceptions about the nature of methods of science were diagnosed using the
    Language English
    Publishing date 2022-05-13
    Publishing country Netherlands
    Document type News
    ZDB-ID 2007131-0
    ISSN 1573-1901 ; 0926-7220
    ISSN (online) 1573-1901
    ISSN 0926-7220
    DOI 10.1007/s11191-022-00338-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  2. Article: Learning about the nature of science through the critical and reflective reading of news on the COVID-19 pandemic.

    García-Carmona, Antonio

    Cultural studies of science education

    2021  Volume 16, Issue 4, Page(s) 1015–1028

    Abstract: The global COVID-19 pandemic caused by the SARS-CoV-2 virus has led to a plethora of information published in the media. Conceived as a socioscientific issue of great relevance currently, this article highlight the educational potential of some media ... ...

    Abstract The global COVID-19 pandemic caused by the SARS-CoV-2 virus has led to a plethora of information published in the media. Conceived as a socioscientific issue of great relevance currently, this article highlight the educational potential of some media news about the pandemic to reflect and learn about the nature of science (NOS). To this end, a theoretical foundation is first presented regarding the reading of science news published in the media as an educational resource to learn about NOS. Secondly, a proposal is presented on how this might be addressed in the science classroom. The proposal is illustrated by four news items, intentionally selected as examples, which have been published in the Spanish digital press. The aspects of NOS that are discussed in the context of the news items selected are: tentativeness of scientific knowledge, role of error in scientific research, role of debate in the development of science, importance of models and modelling in scientific research, and ethics in science.
    Language English
    Publishing date 2021-12-01
    Publishing country Netherlands
    Document type News
    ZDB-ID 2237680-X
    ISSN 1871-1510 ; 1871-1502
    ISSN (online) 1871-1510
    ISSN 1871-1502
    DOI 10.1007/s11422-021-10092-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  3. Article: Spanish Science Teacher Educators' Preparation, Experiences, and Views About Nature of Science in Science Education.

    García-Carmona, Antonio

    Science & education

    2021  Volume 31, Issue 3, Page(s) 685–711

    Abstract: The obstacles and difficulties that science teachers face when teaching the nature of science (NOS) are well-known. Nonetheless, little is known of what science teacher educators (STEs) know, do, and think about this issue. Thus, a study with 142 Spanish ...

    Abstract The obstacles and difficulties that science teachers face when teaching the nature of science (NOS) are well-known. Nonetheless, little is known of what science teacher educators (STEs) know, do, and think about this issue. Thus, a study with 142 Spanish STEs was conducted. This was aimed at analysing (
    Language English
    Publishing date 2021-09-16
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2007131-0
    ISSN 1573-1901 ; 0926-7220
    ISSN (online) 1573-1901
    ISSN 0926-7220
    DOI 10.1007/s11191-021-00263-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  4. Book: Mercados laborales locales y riesgo de exclusión en la región de Murcia

    Losa Carmona, Antonio

    (Editum ágora)

    2014  

    Author's details autores: Antonio Losa Carmona (coord.)
    Series title Editum ágora
    Keywords Regionaler Arbeitsmarkt ; Arbeitslosigkeit ; Arbeitsmarktintegration ; Murcia (Region) ; Spanien
    Language Spanish
    Size 258 S, graph. Darst., Kt.
    Edition 1. ed.
    Publisher Editum, Eds. de la Univ. de Murcia
    Publishing place Murcia
    Document type Book
    Note Enth. 6 Beitr.
    ISBN 9788416038275 ; 8416038279
    Database ECONomics Information System

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  5. Book: Economía aplicada al trabajo social

    Esteban Yago, Miguel A / Losa Carmona, Antonio

    (Formación y desarrollo profesional ; 83)

    2016  

    Author's details Miguel A. Esteban Yago, Antonio Losa Carmona
    Series title Formación y desarrollo profesional ; 83
    Language Spanish
    Size 137 Seiten, Illustrationen
    Edition (Segunda edición, revisada y actualizada)
    Publisher DM, Diego Marín
    Publishing place Murcia
    Document type Book
    ISBN 9788416625659 ; 8416625654
    Database ECONomics Information System

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  6. Article ; Online: Challenges and Adaptation of a European Influenza Vaccine Effectiveness Study Platform in Response to the COVID-19 Emergence: Experience from the DRIVE Project.

    Carmona, Antonio / Muñoz-Quiles, Cintia / Stuurman, Anke / Descamps, Alexandre / Mira-Iglesias, Ainara / Torcel-Pagnon, Laurence / Díez-Domingo, Javier

    International journal of environmental research and public health

    2021  Volume 18, Issue 3

    Abstract: The Development of Robust and Innovative Vaccine Effectiveness (DRIVE) project is a public-private partnership aiming to build capacity in Europe for yearly estimation of brand-specific influenza vaccine effectiveness (IVE). DRIVE is a five-year project ... ...

    Abstract The Development of Robust and Innovative Vaccine Effectiveness (DRIVE) project is a public-private partnership aiming to build capacity in Europe for yearly estimation of brand-specific influenza vaccine effectiveness (IVE). DRIVE is a five-year project funded by IMI (Innovative Medicines Initiative). It was initiated as a response to the guidance on influenza vaccines by EMA (European Medicines Agency), which advised vaccine manufacturers to work with public health institutes to set up a joint IVE study platform. The COVID-19 pandemic reached Europe in February 2020 and overlapped with the 2019/2020 influenza season only in the last weeks. However, several elements of the DRIVE study network were impacted. The pandemic specifically affected the study sites' routines and the subsequent assessment of the 2019/20 influenza season. Moreover, the current social distancing measures and lockdown policies across Europe are expected to also limit the circulation of influenza for the 2020/21 season, and therefore the impact of COVID-19 will be higher than in the season 2019/20. Consequently, DRIVE has planned to adapt its study platform to the COVID-19 challenge, encompassing several COVID-19 particularities in the study procedures, data collection and IVE analysis for the 2020/21 season. DRIVE will study the feasibility of implementing these COVID-19 components and establish the foundations of future COVID-19 vaccine effectiveness studies.
    MeSH term(s) COVID-19 ; Communicable Disease Control ; Europe ; Humans ; Influenza Vaccines/administration & dosage ; Influenza, Human/epidemiology ; Influenza, Human/prevention & control ; Pandemics ; Seasons ; Vaccination
    Chemical Substances Influenza Vaccines
    Language English
    Publishing date 2021-01-25
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2175195-X
    ISSN 1660-4601 ; 1661-7827
    ISSN (online) 1660-4601
    ISSN 1661-7827
    DOI 10.3390/ijerph18031058
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  7. Book: Obra poética

    Pérez Carmona, Antonio

    [1962 - 2004]

    (Biblioteca Antonio Pérez Carmona : Poesía ; 1)

    2013  

    Author's details Antonio Pérez Carmona
    Series title Biblioteca Antonio Pérez Carmona : Poesía ; 1
    Language Spanish
    Size 159 S.
    Edition 1. ed.
    Publisher Ed. El Otro, el Mismo
    Publishing place Mérida, Ven
    Document type Book
    ISBN 9789806523937 ; 9806523938
    Database Former special subject collection: coastal and deep sea fishing

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  8. Article: Brand-specific influenza vaccine effectiveness estimates during 2019/20 season in Europe – Results from the DRIVE EU study platform

    Stuurman, Anke L / Biccler, Jorne / Carmona, Antonio / Descamps, Alexandre / Díez-Domingo, Javier / Muñoz Quiles, Cintia / Nohynek, Hanna / Rizzo, Caterina / Riera-Montes, Margarita

    Vaccine. 2021 June 29, v. 39, no. 29

    2021  

    Abstract: DRIVE (Development of Robust and Innovative Vaccine Effectiveness) is an IMI funded public–private platform that aims to annually estimate brand-specific influenza vaccine effectiveness (IVE), for public health and regulatory purposes. IVE analyses and ... ...

    Institution DRIVE Public Partners
    Abstract DRIVE (Development of Robust and Innovative Vaccine Effectiveness) is an IMI funded public–private platform that aims to annually estimate brand-specific influenza vaccine effectiveness (IVE), for public health and regulatory purposes. IVE analyses and reporting are conducted by public partners in the consortium.In 2019/20, four primary care-based test-negative design (TND) studies (Austria, England, Italy (n = 2)), eight hospital-based TND studies (Finland, France, Italy, Romania, Spain (n = 4)), and one population-based cohort study (Finland) were conducted. The COVID-19 pandemic affected influenza surveillance in all participating study sites, therefore the study period was truncated on February 29, 2020. Age-stratified (6 m-17y, 18-64y, ≥65y), confounder-adjusted, site-specific adjusted IVE estimates were calculated and pooled through meta-analysis. Parsimonious confounder-adjustment was performed, adjusting the estimates for age, sex and calendar time.TND studies included 3531 cases (351 vaccinated) and 5546 controls (1415 vaccinated) of all ages. IVE estimates were available for 8/11 brands marketed in Europe in 2019.Most children and adults < 64y were captured in primary care setting and the most frequently observed vaccine brand was Vaxigrip Tetra. The estimate against any influenza for Vaxigrip Tetra in primary care setting was 61% (95%CI 38–77) in children and 32% (95%CI −13–59) in adults up to 64y. Most adults ≥ 65y were captured in hospital setting and the most frequently observed brand was Fluad, with an estimate of 52% (95%CI 27–68).The population-based cohort covered 511,854 person-years and two vaccine brands. In children aged 2-6y, the IVE against any influenza was 68% (95%CI 58–75) for Fluenz Tetra and 71% (56–80) for Vaxigrip Tetra. In adults ≥ 65y, IVE against any influenza was 29% (20–36) for Vaxigrip Tetra.DRIVE is a growing platform. Public health institutes with surveillance data and hospitals in countries with high influenza vaccine coverage are encouraged to join DRIVE.
    Keywords COVID-19 infection ; cohort studies ; hospitals ; influenza ; influenza vaccines ; meta-analysis ; monitoring ; public health ; Austria ; England ; Finland ; France ; Italy ; Romania ; Spain
    Language English
    Dates of publication 2021-0629
    Size p. 3964-3973.
    Publishing place Elsevier Ltd
    Document type Article
    ZDB-ID 605674-x
    ISSN 1873-2518 ; 0264-410X
    ISSN (online) 1873-2518
    ISSN 0264-410X
    DOI 10.1016/j.vaccine.2021.05.059
    Database NAL-Catalogue (AGRICOLA)

    Full text online

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 1930: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (1.OG)
    ab Jg. 2022: Lesesaal (EG)
    Zs.MO 458: Show issues

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  9. Article ; Online: Post-laser in situ keratomileusis interface Arthrographis kalrae keratitis.

    Fernández-Barrientos, Yolanda / Ramos-Suárez, Antonio / Fernández-Sánchez, Fernando / Tirado-Carmona, Antonio

    Arquivos brasileiros de oftalmologia

    2019  Volume 83, Issue 1, Page(s) 65–68

    Abstract: We describe a case of keratomycosis caused by Arthographis kalrae after excimer laser keratomileusis. A 38-year-old female developed stromal keratitis eight weeks after refractive surgery. She developed severe corneal stromal infiltration and mild ... ...

    Abstract We describe a case of keratomycosis caused by Arthographis kalrae after excimer laser keratomileusis. A 38-year-old female developed stromal keratitis eight weeks after refractive surgery. She developed severe corneal stromal infiltration and mild anterior segment inflammation, which could not be treated with topical voriconazole 1%, but topical natamycin 5% ameliorated her condition. A reactivation of keratomycosis symptoms was observed; therefore, longer treatment was administered to the patient. It has been reported that A. kalrae keratomycosis is associated with exposure to soil and contact lens usage. However, the patient, who lived in a rural location, was neither involved in gardening activities nor had a history of wearing contact lenses. This is the first case of post-refractive A. kalrae keratomycosis.
    MeSH term(s) Adult ; Ascomycota/isolation & purification ; Eye Infections, Fungal/drug therapy ; Eye Infections, Fungal/microbiology ; Female ; Humans ; Keratitis/drug therapy ; Keratitis/microbiology ; Keratomileusis, Laser In Situ/adverse effects ; Natamycin/therapeutic use ; Voriconazole/therapeutic use
    Chemical Substances Natamycin (8O0C852CPO) ; Voriconazole (JFU09I87TR)
    Language English
    Publishing date 2019-09-16
    Publishing country Brazil
    Document type Case Reports ; Letter
    ZDB-ID 603915-7
    ISSN 1678-2925 ; 0004-2749
    ISSN (online) 1678-2925
    ISSN 0004-2749
    DOI 10.5935/0004-2749.20200004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.B 503: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)
    Zs.MO 317: Show issues

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  10. Article ; Online: Brand-specific estimates of influenza vaccine effectiveness for the 2021-2022 season in Europe: results from the DRIVE multi-stakeholder study platform.

    Stuurman, Anke L / Carmona, Antonio / Biccler, Jorne / Descamps, Alexandre / Levi, Miriam / Baum, Ulrike / Mira-Iglesias, Ainara / Bellino, Stefania / Hoang, Uy / de Lusignan, Simon / Bonaiuti, Roberto / Lina, Bruno / Rizzo, Caterina / Nohynek, Hanna / Díez-Domingo, Javier

    Frontiers in public health

    2023  Volume 11, Page(s) 1195409

    Abstract: Introduction: Development of Robust and Innovative Vaccine Effectiveness (DRIVE) was a European public-private partnership (PPP) that aimed to provide annual, brand-specific estimates of influenza vaccine effectiveness (IVE) for regulatory and public ... ...

    Abstract Introduction: Development of Robust and Innovative Vaccine Effectiveness (DRIVE) was a European public-private partnership (PPP) that aimed to provide annual, brand-specific estimates of influenza vaccine effectiveness (IVE) for regulatory and public health purposes. DRIVE was launched in 2017 under the umbrella of the Innovative Medicines Initiative (IMI) and conducted IVE studies from its pilot season in 2017-2018 to its final season in 2021-2022.
    Methods: In 2021-2022, DRIVE conducted four primary care-based test-negative design (TND) studies (Austria, Italy, Iceland, and England; involving >1,000 general practitioners), nine hospital-based TND studies (France, Iceland, Italy, Romania, and Spain, for a total of 21 hospitals), and one population-based cohort study in Finland. In the TND studies, patients with influenza-like illness (primary care) or severe acute respiratory infection (hospital) were enrolled, and laboratory tested for influenza using RT-PCR. Study contributor-specific IVE was calculated using logistic regression, adjusting for age, sex, and calendar time, and pooled by meta-analysis.
    Results: In 2021-2022, pooled confounder-adjusted influenza vaccine effectiveness (IVE) estimates against laboratory-confirmed influenza (LCI) overall and per type and subtype/lineage was produced, albeit with wide confidence intervals (CI). The limited circulation of influenza in Europe did not allow the network to reach the optimal sample size to produce precise IVE estimates for all the brands included. The most significant IVE estimates were 76% (95% CI 23%-93%) for any vaccine and 81% (22%-95%) for Vaxigrip Tetra in adults ≥65 years old and 64% (25%-83%) for Fluenz Tetra in children (TND primary care setting), 85% (12%-97%) for any vaccine in adults 18-64 years (TND hospital setting), and 38% (1%-62%) in children 6 months-6 years (population-based cohort, mixed setting).
    Discussion: Over five seasons, DRIVE collected data on >35,000 patients, more than 60 variables, and 13 influenza vaccines. DRIVE demonstrated that estimating brand-specific IVE across Europe is possible, but achieving sufficient sample size to obtain precise estimates for all relevant stratifications remains a challenge. Finally, DRIVE's network of study contributors and lessons learned have greatly contributed to the development of the COVID-19 vaccine effectiveness platform COVIDRIVE.
    MeSH term(s) Adult ; Aged ; Child ; Humans ; Cohort Studies ; COVID-19 ; COVID-19 Vaccines ; Europe/epidemiology ; Influenza Vaccines ; Influenza, Human/epidemiology ; Influenza, Human/prevention & control ; Seasons ; Vaccine Efficacy ; Male ; Female ; Adolescent ; Young Adult ; Middle Aged
    Chemical Substances COVID-19 Vaccines ; Influenza Vaccines
    Language English
    Publishing date 2023-07-20
    Publishing country Switzerland
    Document type Meta-Analysis ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2711781-9
    ISSN 2296-2565 ; 2296-2565
    ISSN (online) 2296-2565
    ISSN 2296-2565
    DOI 10.3389/fpubh.2023.1195409
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

To top